This week's dividend activity included increased payouts from Visa ( V) and Marathon Petroleum ( MRC) as well as declarations ...

TLDR Novo Nordisk launched an unsolicited $9 billion offer for Metsera, trumping Pfizer’s existing $7.3 billion acquisition ...

Takeda tightened its pipeline in the third quarter. Innovent Biologics reported a head-to-head win against semaglutide in a Chinese phase 3 trial. | Takeda tightened its pipeline in the third quarter.

Futures for the Dow Jones Industrial Average and other major stock indexes traded higher in premarket action Friday as Wall ...

D ow Jones futures edged higher early Friday, while S&P 500 futures and Nasdaq futures rose solidly. Apple AAPL and ...